One of the possible explanations is limitations on our genetic panel not including newer PAH genes such as BMP10, aquaporin 1 (AQP1), ATPase 13A3 (ATP13A3) or kinase insert domain receptor (KDR). The gene discussed is ATP13A3; the disease is pulmonary arterial hypertension.